| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.10. | ViroCell Biologics to Host Panel Event at 2024 Cell & Gene Meeting on the Mesa | 473 | Business Wire | The annual conference will be attended by Team ViroCell, including its newly appointed VP of Corporate Development and Strategy, Nicholas Ostrout, PhD
ViroCell Biologics ("ViroCell" or the "Company")... ► Artikel lesen | |
| 15.08. | ViroCell Biologics Closes Convertible Note Financing | 1 | FinSMEs | ||
| 14.08. | ViroCell Biologics Completes Oversubscribed Convertible Note Offering | 1 | Contract Pharma | ||
| 14.08. | ViroCell Biologics Completes Oversubscribed Financing | 275 | Business Wire | Proceeds will be used to accelerate ViroCell's growth, as it continues to gain commercial traction for its viral vector design and manufacturing services
ViroCell Biologics ("ViroCell" or the "Company")... ► Artikel lesen | |
| 23.07. | ViroCell Signs Master Services Agreement with Prominent Cancer Center | 1 | Contract Pharma | ||
| 23.07. | ViroCell Biologics Signs Master Services Agreement With Prominent NCI-Designated Cancer Center | 283 | Business Wire | MSA enables collaboration on full suite of ViroCell's viral vector manufacturing services to accelerate the cancer center's clinical development of novel gene-modified cell therapies Agreement... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 10.487 |
| EVOTEC | 5.303 |
| SUPER MICRO COMPUTER | 4.591 |
| BAYER | 4.186 |
| NEL | 3.799 |
| MICROSTRATEGY | 2.837 |
| RHEINMETALL | 2.178 |
| TESLA | 1.801 |
| TUI | 1.767 |
| PALANTIR TECHNOLOGIES | 1.488 |
| PORSCHE AG | 1.423 |
| THYSSENKRUPP | 1.423 |
| VOLKSWAGEN | 1.262 |
| BIONTECH | 1.234 |
| COINBASE GLOBAL | 1.222 |
| RENK GROUP | 1.220 |
| GAMESTOP | 1.021 |
| AIXTRON SE | 997 |
| AMAZON | 983 |
| SNOWFLAKE | 969 |
| MERCEDES-BENZ | 920 |
| COMMERZBANK | 915 |
| DEUTSCHE BANK | 914 |
| BYD | 913 |
| BASF | 876 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
